The Latest Clinical Findings for Yokukansan Based on Its Pharmacological Effects: Yokukansan Update
-
- TSUKADA RIKA
- Department of Anesthesiology and Pain Management, Juntendo University Faculty of Medicine
-
- ISEKI MASAKO
- Department of Anesthesiology and Pain Management, Juntendo University Faculty of Medicine
この論文をさがす
抄録
Yokukansan is a formulation containing 15% Uncariae Uncis Cum Ramulus, 10% Bupleuri Radix, 15% Cnidii Rhizoma, 15% Angelicae Radix, 20% Atractylodis Lanceae Rhizoma, 20% Poria and 7% Glycyrrhizae Radix. In addition to its well-established actions on serotonin and glutamate nerve systems, various other effects including suppression of nerve cell excitation, dose-dependent control of brain cell degeneration and protection of nerve sheaths have gradually been elucidated, among which its effectiveness on neuropathic pain has also been evidenced in basic research. In recent years, its wide spectrum of efficacy has given rise to increased use for neuropathic pain along with more conventional applications, such as for treating children’s night cry and symptoms of dementia. Although yokukansan is an easy-to-use formulation, even for elderly patients, care must be taken for the complication of hypokalemia.
収録刊行物
-
- 順天堂醫事雑誌
-
順天堂醫事雑誌 60 (6), 552-558, 2014
順天堂医学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282680495086592
-
- NII論文ID
- 130005075341
-
- NII書誌ID
- AA1262207X
-
- ISSN
- 21882126
- 21879737
-
- NDL書誌ID
- 026519157
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可